Key Real-World Indicators Predict Muscarinic Response in Psychosis
In a groundbreaking advance for psychiatric therapeutics, the recent FDA approval of xanomeline/trospium combination—marketed as Cobenfy—marks a pivotal moment in ...
In a groundbreaking advance for psychiatric therapeutics, the recent FDA approval of xanomeline/trospium combination—marketed as Cobenfy—marks a pivotal moment in ...
A groundbreaking study spearheaded by researchers at NYU Langone Health unveils critical brain circuits that enhance the stability of memories ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine